Merck & Co Inc at Goldman Sachs Healthcare C-Suite Unscripted Conference Transcript
I suspect that people are going to be strolling in, but I don't like to penalize people who are on time. And let's try to stay on time, so let's get underway here.
Welcome to what is, by definition, in my opinion, the keynote presentation of this conference. We are thrilled to have Merck, in particular, Chief Executive Officer, Rob Davis, who is back for a second consecutive year. And we're going to make this an annual tradition. Peter promises me this. He didn't, but I just put the words in his mouth.
So Rob Davis, thank you so much for joining us; and Peter Dannenbaum, the esteemed Investor Relations head and -- who's with us for this conversation here.
Chris Shibutani, member of the Goldman Sachs research team for the health care group. So Rob, I hope you are ready to once again kick off this year providing voice for Merck as we start.
Questions & Answers
And
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
